Related by context. All words. (Click for frequent words.) 75 myelodysplastic syndrome MDS 73 myelodysplastic syndromes MDS 67 B CLL 67 leukemia AML 66 gastrointestinal stromal tumors 65 Amrubicin 65 cell lymphoma CTCL 65 chronic myelogenous leukemia CML 65 lupus nephritis 64 chronic lymphocytic leukemia CLL 64 hematologic disorders 64 metastatic malignant 64 myelofibrosis 64 cell chronic lymphocytic 64 non metastatic osteosarcoma 64 hematologic malignancies 64 systemic lupus erythematosus 64 cutaneous T 64 acute leukemias 64 romiplostim 63 Dacogen injection 63 myelodysplastic syndrome 63 acute myeloid leukemia AML 63 Myelofibrosis 63 Myelodysplastic syndromes MDS 63 Chronic lymphocytic leukemia 63 refractory chronic lymphocytic 63 efalizumab 63 Alemtuzumab 63 nonsmall cell lung cancer 63 Vidaza azacitidine 63 Campath 62 Cutaneous T 62 Gleevec imatinib mesylate 62 metastatic renal cell carcinoma 62 Ceflatonin 62 hematological malignancy 62 cutaneous T cell 62 Rituxan rituximab 62 mycosis fungoides 62 SJIA 62 Troxatyl 62 recurrent NSCLC 62 homozygous familial hypercholesterolemia 62 Ph + ALL 62 chronic myeloid 62 homozygous FH 62 acute myelogenous leukemia AML 62 myelofibrosis polycythemia vera 62 gefitinib Iressa 62 leukemia ALL 62 Myelodysplastic Syndrome 61 erythematosus 61 lymphocytic leukemia 61 refractory Hodgkin lymphoma 61 relapsed ovarian cancer 61 leukemia APL 61 gastrointestinal stromal tumor GIST 61 lymphoma CTCL 61 MYLOTARG 61 Annamycin 61 Vandetanib 61 systemic anaplastic large 61 myeloproliferative disorders 61 chronic myeloid leukemia CML 61 Hodgkin lymphoma HL 61 Peginterferon alfa 2b 61 TTF Therapy 61 azacitidine 61 Hodgkin lymphoma NHL 61 AA amyloidosis 61 YONDELIS 61 vandetanib 61 non squamous NSCLC 61 Clolar 61 Velcade bortezomib 61 malignant pleural mesothelioma 61 refractory metastatic colorectal cancer 61 sunitinib malate 61 dirucotide MBP# 61 terlipressin 61 neuroendocrine tumors 61 Clofarabine 61 Acute myeloid leukemia 61 TEMODAL 61 chemotherapy induced neutropenia 61 acute myeloid 61 chronic idiopathic thrombocytopenic purpura 61 gastrointestinal stromal tumor 60 metastatic renal cell 60 relapsed refractory multiple myeloma 60 myeloproliferative neoplasms 60 unresectable 60 metastatic kidney 60 Actemra 60 rheumatoid arthritis psoriatic arthritis 60 advanced hepatocellular carcinoma 60 neuroendocrine cancers 60 VIDAZA 60 Carcinoid tumors 60 refractory acute myeloid 60 eosinophilic asthma 60 refractory cutaneous T 60 Vidaza 60 purpura ITP 60 SHPT 60 subependymal giant cell 60 Xanafide 60 myelodysplastic myeloproliferative diseases 60 aHUS 60 hypoparathyroidism 60 Torisel 60 Phenoptin 60 taxane chemotherapy 60 soft tissue sarcomas 60 Herceptin trastuzumab 60 pemphigus vulgaris 60 Morquio 60 Plicera 60 Myelodysplastic Syndrome MDS 60 relapsing remitting 60 essential thrombocythemia 60 Hepatocellular Carcinoma HCC 60 ixabepilone 60 Acute Myelogenous Leukemia AML 60 myelofibrosis MF 60 HER2 positive metastatic breast 60 HuMax CD4 60 Myelodysplastic syndromes 60 Bronchiectasis 60 recurrent glioblastoma multiforme 60 heterozygous FH 60 Campath ® 60 Fludarabine 60 cytopenias 60 deletion 5q 60 Chronic Lymphocytic Leukemia 60 refractory acute promyelocytic 60 Evoltra ® 60 cell lymphoma ALCL 60 relapsed leukemia 60 cell acute lymphoblastic 59 Nexavar sorafenib 59 hepatocellular cancer 59 Merck KGaA Erbitux 59 Ambrisentan 59 Promacta 59 cytotoxic chemotherapy 59 figitumumab 59 stage IIIB 59 pancreatic NET 59 renal cell carcinoma 59 Follicular Lymphoma 59 acute coronary syndromes ACS 59 myelodysplasia 59 corticosteroid dexamethasone 59 metastatic colorectal 59 Pirfenidone 59 Zolinza 59 IL# PE#QQR 59 Lenalidomide 59 TTR amyloidosis 59 chronic lymphocytic leukemia 59 dasatinib 59 Gleevec imatinib 59 Celgene Revlimid 59 Novantrone 59 adult chronic ITP 59 Ceflatonin R 59 chronic immune thrombocytopenic 59 relapsed refractory 59 IV NSCLC 59 Dacogen decitabine 59 pulmonary arterial hypertension 59 systemic lupus erythematosus SLE 59 non alcoholic steatohepatitis 59 chronic thromboembolic pulmonary 59 non squamous 59 Dasatinib 59 Clolar ® 59 phenylketonuria 59 Gleevec resistant 59 OPAXIO 59 indolent NHL 59 Revlimid lenalidomide 59 metastatic bladder 59 dirucotide 59 Li Fraumeni Syndrome 59 axitinib 59 severe malignant osteopetrosis 59 secondary hyperparathyroidism 59 smoldering myeloma 59 invasive candidiasis 59 multiple myeloma 59 RSR# 59 Glioblastoma Multiforme 59 pazopanib 59 phase IIb clinical 59 relapsing remitting multiple sclerosis 59 systemic juvenile idiopathic 59 Toxicities 59 posterior uveitis 59 Alzhemed TM 59 bevacizumab Avastin 59 standard chemotherapy regimens 59 Ph + CML 59 Folotyn 59 leukemia CLL 59 phase IIb trial 59 severe hypercholesterolemia 59 advanced metastatic renal 59 idiopathic thrombocytopenic purpura 59 carcinoid tumors 59 Voreloxin 59 Acute Myeloid Leukaemia AML 59 metastatic GIST 59 Acute Myeloid Leukemia AML 59 Chronic myeloid leukemia 59 pediatric acute lymphoblastic 59 histone deacetylase HDAC inhibitor 59 carcinoid 59 acute GvHD 59 hereditary angioedema 59 HBeAg negative 58 Romiplostim 58 pralatrexate 58 vinorelbine 58 BAY #-# 58 Epratuzumab 58 potentially hepatotoxic 58 proteasome inhibitor 58 complement inhibitor eculizumab 58 sorafenib Nexavar 58 oligodendrogliomas 58 myeloproliferative diseases 58 tanespimycin 58 cladribine 58 HuLuc# 58 Cabazitaxel 58 idiopathic pulmonary fibrosis IPF 58 juvenile idiopathic arthritis JIA 58 docetaxel Taxotere R 58 Jevtana 58 MELAS 58 chronic eosinophilic leukemia 58 hepatorenal syndrome 58 carcinoid syndrome 58 haematologic malignancies 58 Omacetaxine 58 GW# [003] 58 cardio renal 58 haematologic 58 Leukine ® 58 clofarabine 58 HeFH 58 hormone refractory prostate cancer 58 visilizumab 58 Acute Myeloid Leukemia 58 Chronic lymphocytic leukemia CLL 58 Firazyr 58 advanced metastatic prostate 58 hypophosphatasia 58 hypereosinophilic syndrome 58 malignant pheochromocytoma 58 erlotinib Tarceva ® 58 TREANDA 58 adverse cytogenetics 58 mRCC 58 histologies 58 atypical Hemolytic Uremic Syndrome 58 TELINTRA 58 CTEPH 58 Navelbine ® 58 Azacitidine 58 temsirolimus 58 SNT MC# 58 grade gliomas 58 calcineurin inhibitors 58 grade cervical intraepithelial 58 Campath alemtuzumab 58 sorafenib tablets 58 tuberous sclerosis TS 58 Revlimid 58 amrubicin 58 opioid induced constipation OIC 58 Acute Myelogenous Leukemia 58 familial hypercholesterolemia 58 tafamidis 58 Actimmune ® 58 Severe Primary IGFD 58 Sorafenib 58 NYHA Class II 58 nephropathic cystinosis 58 Cushing Syndrome 58 Alessandro Riva 58 hypercalcemia 58 refractory APL 58 Philadelphia Chromosome Positive 58 anthracyclines 58 chronic granulomatous disease 58 IBS C 58 Amigal 58 follicular lymphoma FL 58 Chronic Myeloid Leukemia 58 chronic ITP 58 metastatic gastric 58 hematological diseases 58 hematological malignancies 58 erlotinib Tarceva 58 Zavesca 58 myeloproliferative disorder 58 imatinib resistant 58 leukemia multiple myeloma 58 Avastin bevacizumab 58 imatinib Gleevec 58 HoFH 58 Lupus nephritis 58 Fabry Disease 58 refractory multiple myeloma 58 Vectibix 58 Leukemias 58 decitabine 58 Friedreich Ataxia FRDA 58 AML acute myeloid 58 Esbriet 57 Pixantrone 57 Myelodysplastic syndrome 57 PEGylated interferon beta 1a 57 Phase #/#a trial 57 canakinumab 57 receptor tyrosine kinase inhibitor 57 Corlux 57 atypical hemolytic uremic syndrome 57 cediranib 57 investigational therapies 57 Onrigin 57 cabazitaxel 57 Genentech Rituxan 57 gastrointestinal stromal tumors GIST 57 bosutinib 57 Acute myeloid leukemia AML 57 SPRYCEL ® 57 dasatinib Sprycel ® 57 MGd 57 pediatric Crohn disease 57 FOLOTYN ® 57 malignant ascites 57 PNP inhibitor 57 platinum refractory 57 metastatic malignant melanoma 57 cancer cachexia 57 Treanda 57 reslizumab 57 AAT deficiency 57 Uricase PEG 57 thalidomide Thalomid 57 nilotinib 57 refractory indolent non 57 relapsing multiple sclerosis 57 juvenile myelomonocytic leukemia 57 gemcitabine chemotherapy 57 post transplant lymphoproliferative 57 MAGE A3 ASCI 57 pegylated interferons 57 tumors GIST 57 Letairis ambrisentan 57 Cloretazine 57 Pemetrexed 57 Vectibix panitumumab 57 vWD 57 Icatibant 57 Ilaris 57 sJIA 57 pirfenidone 57 Gleevec Glivec 57 haematological malignancies 57 dasatinib Sprycel 57 papillary renal cell carcinoma 57 TACI Ig 57 Mepact 57 immune thrombocytopenic purpura 57 Votrient 57 autoantibody positive 57 Sezary syndrome 57 relapsed MM 57 systemic ALCL 57 LAF# 57 eculizumab 57 Arcalyst 57 candidemia 57 MPS VI 57 A1PI 57 refractory AML 57 BENLYSTA ® 57 vemurafenib 57 esophageal candidiasis 57 stage IIIB IV 57 Evoltra 57 BRAF inhibitor 57 iniparib 57 medullary thyroid cancer 57 PegIntron 57 pulmonary arterial hypertension PAH 57 Tarceva erlotinib 57 paroxysmal nocturnal hemoglobinuria 57 Chronic Lymphocytic Leukemia CLL 57 relapsed SCLC 57 maribavir 57 Nilotinib 57 Temsirolimus 57 INCB# [003] 57 herpetic keratitis 57 sargramostim 57 Pivotal Phase III 57 multiple myeloma MM 57 essential thrombocythemia ET 57 differentiated thyroid 57 myeloid 57 Yervoy 57 Taxotere docetaxel 57 Waldenstrom macroglobulinemia 57 imatinib Gleevec ® 57 Orphan Drug status 57 motesanib 57 Idiopathic Thrombocytopenic Purpura ITP 57 mifamurtide 57 relapsed multiple myeloma 57 common hematologic malignancy 57 anti angiogenic agents 57 PEG PAL 57 antibody MAb 57 diabetic gastroparesis 57 post herpetic neuralgia PHN 57 IAP inhibitor 57 Fibrillex TM 57 pulmonary hypertension PH 57 juvenile idiopathic arthritis 57 monoclonal antibody conjugated 57 Nexavar tablets 57 familial amyloidotic polyneuropathy FAP 57 Myelodysplasia 57 TRISENOX 57 ocrelizumab 57 PNH patients 57 FTY# 57 alogliptin 57 alvespimycin 57 idiopathic thrombocytopenic purpura ITP 57 Phase III randomized controlled 57 AVASTIN 56 Enzyme Replacement Therapy 56 chronic plaque psoriasis 56 R vitespen 56 rALLy 56 Diffuse Large B 56 kidney urologic 56 Cetrorelix 56 Aviptadil 56 Brentuximab Vedotin SGN 56 Zarnestra 56 generation purine nucleoside 56 anemia neutropenia 56 efaproxiral 56 squamous cell lung cancer 56 pancreatic neuroendocrine tumors 56 recurrent ovarian cancer 56 Myfortic 56 EGFR inhibitors 56 alemtuzumab Campath 56 bendamustine 56 TNF Tumor Necrosis Factor 56 interferon therapy 56 Aryplase 56 hoFH 56 Camptosar 56 ankylosing spondylitis 56 cisplatin chemotherapy 56 Medicinal Products EMEA 56 Erlotinib 56 QVA# 56 radiation sensitizer 56 Sprycel 56 Sudhir Agrawal D.Phil 56 biologic therapy 56 PXD# 56 Sjogren Syndrome 56 HQK 56 advanced unresectable 56 OvaRex ® MAb 56 progressive multifocal leukoencephalopathy PML 56 RoACTEMRA 56 lymphoid malignancies 56 CYT# potent vascular disrupting 56 polycythemia vera PV 56 LHRH agonists 56 Kit CD# positive 56 gemcitabine carboplatin 56 Fibrillex 56 lintuzumab SGN 56 low dose cytarabine 56 cetuximab Erbitux 56 acute myeloid leukemia 56 nonalcoholic steatohepatitis NASH 56 tasocitinib 56 alkylating agent 56 velaglucerase alfa 56 cetuximab Erbitux ® 56 allogeneic stem cell 56 Certolizumab pegol 56 TNF antagonist 56 rheumatoid arthritis psoriasis 56 Mabthera 56 small lymphocytic lymphoma 56 Soliris eculizumab 56 Tasimelteon 56 smoldering multiple myeloma 56 malignant neoplasm 56 Mipomersen 56 ara C 56 AEG# 56 Inflammatory bowel disease 56 anemias 56 tocilizumab 56 metastatic uveal melanoma 56 darapladib 56 evaluating REVLIMID 56 Tasigna nilotinib 56 EGFR expressing 56 thymoma 56 infusional 5-FU/LV 56 Systemic lupus erythematosus 56 Riluzole 56 arthritis SJIA 56 ANCA associated 56 R sorafenib tablets 56 Telcyta 56 Cell Lymphoma 56 Nplate 56 Myelodysplastic Syndromes MDS 56 Junovan 56 IV melanoma 56 ceroid lipofuscinosis NCL 56 mipomersen 56 mCRC 56 Lung transplantation 56 cancer neuroendocrine tumor 56 Trastuzumab 56 relapsed Acute Myeloid 56 relapsing forms 56 Vaprisol 56 Revolade 56 hepatocellular carcinoma 56 Dacogen 56 xanthine oxidase inhibitor 56 cirrhosis liver failure 56 Arranon 56 IV metastatic melanoma 56 VEGF inhibitors 56 DOXIL 56 Abiraterone acetate 56 cetuximab Erbitux R 56 unresectable recurrent 56 Allovectin 7 56 lumiliximab 56 Mylotarg 56 Hereditary angioedema HAE 56 myeloproliferative 56 relapsed acute lymphoblastic 56 hereditary angioedema HAE 56 recurrent glioblastoma 56 BLP# Liposome Vaccine 56 refractory NSCLC 56 fingolimod 56 luteinizing hormone releasing 56 calcineurin inhibitor 56 Chronic Myelogenous Leukemia CML 56 cytogenetic abnormalities 56 Fabry disease 56 non splenectomized 56 unfavorable cytogenetics 56 alemtuzumab 56 vascular disrupting agent 56 Systemic lupus erythematosus SLE 56 Sutent sunitinib 56 Rebif ® 56 schizophrenia CIAS 56 grade glioma 56 INSPIRE Trial Phase III 56 Everolimus 56 fluvastatin 56 Glioblastoma multiforme GBM 56 postherpetic neuralgia 56 Fludara ® 56 baminercept 56 hypomethylating agents 56 rFVIIa 56 Idiopathic pulmonary fibrosis 56 ambrisentan 56 pheochromocytoma 56 bone metastases 56 chemotherapeutic regimen 56 metastatic hormone refractory 56 aflibercept 56 clazosentan 56 hematological cancers 56 fallopian tube carcinoma 56 NAGS deficiency 56 Starlix 56 PEGINTRON TM 56 leukaemias 56 chronic myocardial ischemia 56 TBC# 56 Actemra tocilizumab 56 relapsing remitting MS RRMS 56 Ceflatonin ® 56 iniparib BSI 56 Soft Tissue Sarcoma 56 primary Restless Legs 56 advanced carcinoid 56 metastatic castration resistant 56 recurrent colorectal cancer 56 vorinostat 56 psoriatic arthritis PsA 56 hepatocellular carcinoma HCC 56 Anaplastic 56 hereditary antithrombin deficiency 56 somatostatin analogues 56 interferon alfa 56 galiximab 56 NSCLC 56 Metastatic breast cancer 56 targeted radiotherapeutic 56 immunodeficiencies 56 STRIDE PD 56 Nebido 56 refractory gout 56 palifermin 56 docetaxel chemotherapy 56 metastatic colorectal cancer 56 anaplastic astrocytoma 56 romidepsin 56 polycythemia vera essential thrombocythemia 56 Chronic Myelogenous Leukemia 56 basal cell carcinoma BCC 56 Follicular lymphoma 56 CHOP chemotherapy 56 Aplidin 56 Natalizumab 56 paroxysmal nocturnal hemoglobinuria PNH 56 Revlimid pill 56 cell carcinoma RCC 56 Bevacizumab 56 idursulfase 56 sorafenib 56 K ras mutations 56 fungoides 56 CEQ# 56 imatinib mesylate 56 Saxagliptin 56 zalutumumab 56 tyrosine kinase inhibitors TKIs 55 Orphan Medicinal Product 55 rufinamide 55 CLL SLL 55 transplantation HCT 55 Tanespimycin 55 pediatric malignancies 55 Acute lymphoblastic leukemia 55 metastatic renal 55 AA Amyloidosis 55 Asentar 55 NATRECOR R 55 daclizumab 55 tyrosine kinase inhibitors 55 VAPRISOL 55 inhibitor RG# 55 Basal cell 55 allogeneic bone marrow 55 Diamyd ® 55 bortezomib Velcade 55 pomalidomide 55 teriflunomide 55 castrate resistant prostate cancer 55 TNF blockers 55 diagnosed Ph + 55 oxypurinol 55 basiliximab 55 INCB# [001] 55 irinotecan chemotherapy 55 alvimopan 55 bronchogenic carcinoma 55 Tumor Necrosis Factor 55 Major Depressive Disorder MDD 55 PrevOnco 55 elotuzumab 55 metastatic castrate resistant 55 MabThera Rituxan 55 Azedra 55 Etanercept 55 Cinryze TM 55 commercialize deforolimus 55 tumor lysis syndrome 55 gastrointestinal stromal 55 Gemzar gemcitabine 55 Idiopathic Pulmonary Fibrosis 55 rheumatoid arthritis Crohn disease 55 epithelial tumors 55 untreated AML 55 Non Hodgkin 55 PAOD 55 primary hypercholesterolemia 55 denileukin diftitox 55 sorafenib Nexavar ® 55 Phase IIb clinical trials 55 Glivec imatinib 55 Fludara 55 Ocrelizumab 55 Cimzia ® certolizumab pegol 55 arthritis PsA 55 Ibritumomab Tiuxetan 55 Gaucher disease 55 ZACTIMA 55 hypercholesterolaemia 55 Cloretazine R 55 glioblastoma multiforme GBM 55 Raptiva R 55 blinatumomab 55 chlorambucil 55 Relapsing Remitting Multiple Sclerosis 55 hematologic toxicity 55 torsade de pointes 55 pancreatic carcinoma 55 Glufosfamide 55 docetaxel Taxotere ® 55 BRIM2 55 Neuvenge 55 anthracyclines taxanes 55 NOMID 55 MKC# MT 55 trabectedin 55 Specifid 55 depsipeptide 55 Pegintron 55 serologically active systemic lupus 55 sunitinib 55 Relapsed Refractory 55 Non Hodgkin lymphoma 55 MKC# MKC# PP 55 rituximab Rituxan 55 fibromyalgia syndrome 55 ASA# 55 paclitaxel Taxol ® 55 glufosfamide 55 Afinitor 55 everolimus tablets 55 Novartis Gleevec 55 panitumumab Vectibix 55 tyrosine kinase inhibitor 55 Critical Limb Ischemia CLI 55 EFAPROXYN 55 Irinotecan 55 minimally symptomatic 55 ACZ# 55 squamous non 55 follicular thyroid cancer 55 castration resistant 55 Removab 55 medically inoperable 55 inflammatory autoimmune 55 6R BH4 55 forodesine 55 curative therapy 55 natalizumab 55 CytoFab 55 pancreatic islet cell 55 HER2 positive breast cancer 55 mycophenolate mofetil 55 Sanofi Aventis Taxotere 55 Hepatocellular Carcinoma 55 muscular dystrophy cystic fibrosis 55 post herpetic neuralgia 55 Atypical Hemolytic Uremic Syndrome 55 gastric carcinoma 55 Squamous 55 polyneuropathy CIDP 55 chemotherapeutic agent 55 Allovectin 7 ® 55 von Willebrand disease 55 Ribavirin causes 55 Paraplatin ® 55 bladder ovarian 55 mixed hyperlipidemia 55 castration resistant prostate cancer 55 LymphoStat B belimumab 55 sunitinib Sutent 55 bone marrow suppression 55 adalimumab Humira 55 Avonex interferon beta 1a 55 dacarbazine 55 nasopharyngeal carcinoma 55 Tygacil 55 iGVHD 55 acyclovir Lauriad R 55 Peripheral neuropathy 55 Orathecin 55 TheraSphere 55 Nuvion 55 drug figitumumab 55 Hurthle cell 55 Noxafil 55 Wegener granulomatosis 55 LymphoStat B 55 hepatocellular carcinomas 55 Esbriet pirfenidone 55 gastrointestinal cancers 55 RITUXAN 55 Cellcept 55 Krystexxa 55 superficial basal cell carcinoma 55 anidulafungin 55 Parnate 55 astrocytomas 55 Cinquil 55 orphan drug 55 VEGF Trap 55 gemcitabine Gemzar ® 55 follicular Non Hodgkin 55 treating chronic myeloid 55 diabetic kidney 55 Gaucher Disease 55 Cloretazine ® 55 Folfox 55 oral cladribine 55 leukemic 55 ATTR 55 invasive aspergillosis 55 immune thrombocytopenic purpura ITP 55 dyslipidemia 55 progressive neurodegenerative disorder 55 cinacalcet HCl 55 Ixempra 55 gastrointestinal mucositis 55 Zorbtive TM 55 Telintra 55 untreated de novo 55 ZACTIMA TM ZD# 55 Mitoxantrone 55 gastrointestinal stromal tumors GISTs 55 Cimzia TM 55 cardiotoxicity 55 OHR/AVR# 55 GvHD 55 nonmetastatic 55 symptomatic neurogenic orthostatic hypotension 55 Gilenia 55 Evoltra TM 55 Neurodex 55 hemolytic anemia 55 refractory peripheral T 55 Acute Bacterial Sinusitis ABS 55 abiraterone acetate 55 lymphoma subtypes 55 Oxaliplatin 55 Arzerra ofatumumab 55 Estybon ™ 55 post operative ileus 55 Archexin 55 AGILECT R 55 Belimumab 55 FRDA 55 Maribavir 55 Vidaza ® 55 Roche Actemra 55 unresectable stage 55 IgG1 monoclonal antibody 55 refractory chronic myeloid 55 idarubicin 55 benign prostatic hyperplasia 55 Myelodysplastic Syndromes 55 IMA# 55 PDX pralatrexate 55 ThermoDox R 55 neuronal ceroid lipofuscinosis NCL 55 brain metastases 55 severe oral mucositis 55 lung pancreatic 55 Mantle Cell Lymphoma 55 indolent follicular non 55 Metastatic 55 non Hodgkin lymphomas 55 Esbriet ® 55 follicular lymphoma 55 Omapro 55 DPP4 inhibitor 55 midstage studies 55 debilitating autoimmune 55 hepatic encephalopathy HE 55 eribulin mesylate 54 Pazopanib 54 MPGN 54 Orphan Drug designations 54 angioedema 54 ACTEMRA TM 54 L MTP PE 54 Bortezomib 54 Medidur ™ FA 54 HER2 + 54 Panitumumab 54 Nexavar ® 54 Taxotere ® 54 acute PAO 54 Denufosol 54 Gattex 54 eltrombopag 54 refractory CLL 54 resistant ovarian cancer 54 palliative radiotherapy 54 severe gastroparesis 54 Eprodisate KIACTA TM 54 Hycamtin ® 54 Rilonacept 54 solid tumors 54 lomitapide 54 sapacitabine 54 ELACYT 54 drug Treanda 54 Tykerb lapatinib 54 mTOR inhibitor 54 Kepivance 54 panitumumab 54 Eculizumab 54 ofatumumab HuMax CD# 54 Lupus Nephritis 54 recurrent glioblastoma multiforme GBM 54 hepatotoxicity 54 FOLFOX chemotherapy 54 refractory metastatic 54 ADPKD 54 optica 54 Arzerra 54 enzastaurin 54 leukemias lymphomas 54 LHON 54 Raptiva ® 54 MALT lymphoma 54 IMiDs 54 peripheral neuropathic pain 54 Wafer polifeprosan 54 Marqibo 54 L BLP# 54 Afinitor everolimus 54 peritumoral brain edema 54 RG# [001] 54 transthyretin amyloidosis 54 lymphoid blast 54 relapsing remitting MS 54 Leber Hereditary Optic Neuropathy 54 Advexin 54 Bayer Nexavar 54 Daclizumab 54 Juvenile Idiopathic Arthritis JIA 54 colon lung 54 Benlysta belimumab 54 rilonacept 54 transplantation HSCT 54 atherothrombotic events 54 chemotherapy induced thrombocytopenia 54 induced macular edema 54 venous thromboembolic events 54 formerly LymphoStat B 54 chronic angina 54 acetonide FA 54 TACE 54 arthritis RA 54 Acute myelogenous leukemia 54 Trovax 54 Cimzia certolizumab pegol 54 CDP# 54 refractory anaplastic astrocytoma 54 noninfectious uveitis 54 pancreatic enzyme replacement 54 Nuedexta 54 ® lenalidomide 54 Cimzia 54 rheumatoid arthritis RA psoriatic 54 adriamycin 54 Adcirca 54 Advanced Renal Cell 54 Golimumab 54 Taxotere chemotherapy 54 Doxil ® 54 proliferative diabetic retinopathy 54 metaglidasen 54 mixed dyslipidemia 54 skeletal muscle weakness 54 Phase #b/#a clinical 54 Chronic ITP 54 cutaneous squamous cell carcinoma 54 temozolomide Temodar